reported that CLPTM1L directly interacts with and acts as a coactivator of the transcription factor ERβ, leading to the activation of ERβ target genes in NSCLC cells and thereby promoting radio resistance (30). Here, ESR2 is linked to non-small cell lung carcinoma.